Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of specialty insurer Global Indemnity (Nasdaq: GBLI) surged 17% on Friday after announcing a preliminary evaluation of strategic alternatives.

So what: According to Global, one of those strategic options includes "discussions with potential acquirers," so it's no surprise that Mr. Market is bidding up the shares in anticipation of a buyout. Global has done well to navigate a difficult pricing environment over the past few years, but with its shares consistently trading well under book value (even with today's pop), management seems to be taking a more active approach in "unlocking" shareholder value.

Now what: I'd be careful about buying into the buyout buzz. In today's press release, Global made sure to note that "there can be no assurance that this process will lead to a transaction," so betting on the stock based purely on takeover-talk seems risky. Unless you'd be perfectly willing to own Global as a long-term standalone investment, it's probably best to watch the process unfold from a distance.    

Interested in more info on Global Indemnity? Add it to your watchlist.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.